Fermentation is part of the basic process of biotechnological production. If fermentation approaches are to be scaled up from laboratory to production scale, some approaches go from the already larger format back to the small laboratory format until the large-scale fermentation approach is ready. We asked two experts from BRAIN about fermentation, planning; the technical challenges and trends.
BRAIN and Roquette have signed a contractual agreement for the approval and production of the sweet protein brazzein. The sweetener could be brought to market within the next three to four years.
Biosun Biochemicals Inc.(U.S.) d/b/a BIOSUN FLAVORS & FOOD INGREDIENTS (BIOSUN FFI) has been part of the BRAIN Group since January 1, 2021. Among other things, it will help to expand the Group´s sales and manufacturing capacities in North America.
Which enzyme do you like to use? Of animal or microbial origin? Biocatalysts Ltd is dedicated to the development and production of a range of microbial alternative enzymes for the food and pet food industry and has recently launched a protease specifically for the pet food market.
The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization to the Convention on Biological Diversity has been in force for ten years. Here is an overview of the history of the agreement and an interview with BRAIN employee Dr. Dirk Sombroek on the significance of the agreement for biotechnology companies like BRAIN.
